PT-141 Driada Medical Bremelanotid 10mg for Sale. Buy original Peptides with 100% delivery rate from the Anabolic Shop Driada-steroids.com.

PT-141 Driada Medical Bremelanotid 10mg

Driada Medical PT-141 Bremelanotid 10mg is a medication used to treat hemorrhagic shock, reperfusion injury, and female sexual dysfunction. It minimizes ischemia, regulates inflammation, and activates the MC1R and MC4R melanocortin receptors. The medication was first investigated for use as an intranasal treatment for female sexual dysfunction; however, in 2008, reports of negative side effects, including elevated blood pressure, forced the temporary suspension of the drug’s research for this purpose. As of March 2012, Palatin Technologies was employing subcutaneous injection of the medicine to undertake a phase 2B trial on humans. The drug’s producer believes the study will not affect blood pressure.

Peptid Bremelanotid 10mg

Driada Medical PT-141 Melanotan 2, a peptide hormone studied as a tanning agent without sun exposure, is the source of Bremelanotid. Initial tests revealed that Melanotan 2 did more than just tan; it also induced sexual excitement and spontaneous erections. Research has demonstrated that bemelanotide is useful in treating sexual dysfunction in women (sexual arousal disorder) and men (erectile dysfunction). Bremelanotide directly stimulates desire by acting on the neural system, in contrast to Viagra and other similar medications that affect the vascular system.

PT-141 Driada Medical Bremelanotid Mechanism of action

Driada Medical PT-141 Bremelanotid is an analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) that stimulates the central nervous system’s MC3-R and MC4-R melanocortin receptors. Bremelanotide’s centrally mediated action makes it a promising treatment for erectile dysfunction. It may also be used to address unmet medical needs related to libido loss and diminished sexual motivation.

Facts about PT-141 Driada Medical Peptid

Strong erection inducer PT-141 Driada Medical Bremelanotide has a short half-life, few adverse effects, and a quick start. Notably, new phase II research verifies that sexual stimulation enhances erectile responses. Owing to its primary mode of action, PT-141 Driada Medical Bremelanotid functions both independently and in concert with PDE-5 inhibitors (Cialis, Viagra), offering a valuable substitute treatment for erectile dysfunction resulting from both organic and psychogenic causes.

A randomized, prospective, placebo-controlled study contrasted the use of 141 intranasal PT doses of Sildenafil for the treatment of ED.

When two medications were taken together, it took much longer (>60%) to raise the stiffness of the base during a 2.5-hour monitoring period than when Sildenafil was taken alone. When compared to sildenafil pot PT-alone, the medication combination was well tolerated and did not significantly enhance adverse effects.

Driada Medical Bremelanotid Effects

The erectogenic potential of PT-, its tolerability profile, and its ability to induce significant erections in patients who do not have an adequate response to a PDE inhibitor (Syslais, Viagra) suggest that PT- may provide an alternative treatment.
Increase of sexual desire and erection

Side effects from PT-141 Driada Medical

Nausea
Hot flush
Headache

How to use Peptides correct?

The first erection occurs in about 30 minutes. The peak concentration of the substance in the blood falls in 60 minutes after the injection and gradually decreases in 4 hours.
Combination with other drugs
For a better effect, it can be used with drugs such as Sildenafil and Tadafil.

How to prepare a solution with Peptide

A syringe pre-filled with diluent is used to prepare an injection solution, which is then injected into a vial containing lyophilized powder. Make sure the needle reaches the bottle wall by tilting the container. Do not directly inject the diluent into the powder that has been lyophilized. Take your time and fill the bottle one at a time; the solvent should gradually run down the wall. After adding all the diluent to the peptide vial, stir the mixture gently (do not shake or agitate the vial) until the lyophilized powder dissolves and a clear liquid is left behind. The medication can now be used.

Never combine different peptides in the same syringe. This may break delicate peptide molecules.

Product Usage

The injection can be subcutaneous, intramuscular depending on personal preference.

Product Storage

The resultant solution keeps well in a refrigerator between 2 and 8 degrees Celsius for about 21 days. If bacteriostatic water is used to make the solution, the storage period is extended.